v3.26.3
Investments and Fair Value Measurements (Tables)
 6 Months Ended
Sep. 30, 2026
Fair Value Disclosures [Abstract]  
Schedule of Investments
Our investments related to unconsolidated entities included in other long-term assets of the Company’s consolidated balance sheets at September 30, 2026 and March 31, 2026 were:
InvestmentsSeptember 30,
2026		March 31,
2026
Equity method investments$322 $184 
Other investments197 160 
Total Investments$519 $344 
Schedule of Recurring Fair Value Measurements
The financial instruments measured at fair value on a recurring basis in the accompanying condensed consolidated balance sheets consisted of the following at the periods presented below:
September 30, 2026March 31, 2026
Level 1Level 2TotalLevel 1Level 2Total
Assets:
Money market funds$262 $— $262 $307 $— $307 
Long-term deferred compensation plan asset44 — 44 40 — 40 
Total Assets$306 $— $306 $347 $— $347 
Liabilities:
Current derivative instruments$— $— $— $— $1 $1 
Long-term deferred compensation plan liability44 — 44 40 — 40 
Total Liabilities$44 $— $44 $40 $1 $41 
Schedule of Carrying Values and Estimated Fair Values of Debt Instruments The carrying amount and estimated fair value of long-term debt for the periods presented are as follows:
September 30, 2026March 31, 2026
Carrying AmountEstimated Fair ValueCarrying AmountEstimated Fair Value
Term Loans$741 $734 $1,464 $1,455 
Senior Notes3,700 3,567 2,500 2,482 
Total Debt$4,441 $4,301 $3,964 $3,937